Business NewsPR NewsWire • New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer's disease, says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.

New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer's disease, says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.

New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer's disease, says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.

NAPLES, Fla., April 9, 2019 /PRNewswire/ -- New government research grant funds targeted at infectious agents will accelerate investigations into the possible roles of germs in triggering or promoting Alzheimer's disease," says Leslie Norins, MD, PhD, CEO of Alzheimer's Germ Quest, Inc....

View More : https://www.prnewswire.com:443/news-releases/new-nih-funding-for-studies-of-suspicious-microbes-will-accelerate-solving-...
Releted News by prnewswire
Polygon Expects Significant Valuation Uplift Following Realia Business, S.A. Adoption of RICS Standard
OMRON Introduces 181 Models in 6 Categories to World, Fifth Wave of Control Panel Equipment for Factory Automation Built on Common Design Platform
New NIH funding for studies of suspicious microbes will accelerate solving Alzheimer's disease, says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.
NPI Hires Tara L. Kelly as Global Executive Assistant to Help Oversee Domestic and International Operations
Wirecard and Al Ansari Exchange Collaborate to Launch Enhanced Multi-currency Travel Card Solution
Diet Rich in Animal Protein is Associated With a Greater Risk of Death